Adverum Biotechnologies Q4 EPS $(1.96) Misses $(1.38) Estimate

Benzinga · 5d ago
Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(1.96) per share which missed the analyst consensus estimate of $(1.38) by 42.03 percent. This is a 14.78 percent increase over losses of $(2.30) per share from the same period last year.